Literature DB >> 11673556

Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis.

T Nanki1, K Nagasaka, K Hayashida, Y Saita, N Miyasaka.   

Abstract

Rheumatoid arthritis (RA) is characterized by proliferation of synoviocytes that produce inflammatory cytokines and chemokines. The expressed chemokines are thought to be involved in the migration of inflammatory cells into the synovium. In this study we show that CCL2/monocyte chemotactic protein-1, CCL5/RANTES, and CXCL12/stromal cell-derived factor-1 enhanced IL-6 and IL-8 production by fibroblast-like synoviocytes (FLS) from patients with RA, and their corresponding receptors, CCR2, CCR5, and CXCR4, respectively, were expressed by RA FLS. The chemokines stimulated RA FLS more effectively than skin fibroblasts. Culture with CCL2 enhanced phosphorylation of extracellular signal-related kinase 1 (ERK1) and ERK2, but not phosphorylation of p38 or Src. Moreover, activation of ERK1/2 was inhibited by pertussis toxin, a G(i)-coupled protein inhibitor, and RS-504393, CCR2 antagonist, suggesting that ERK1/2 was activated by CCL2 via CCR2 and G(i)-coupled protein. On the other hand, CCL2, CCL5, and CXCL12 were expressed on RA FLS, and their production was regulated by TNF-alpha, IL-1beta, and TGF-beta1. Our results indicate that the chemokines not only play a role in inflammatory cell migration, but are also involved in the activation of FLS in RA synovium, possibly in an autocrine or paracrine manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673556     DOI: 10.4049/jimmunol.167.9.5381

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

Review 1.  Chemokines--linking receptors to response.

Authors:  Malcolm L Watson
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

2.  CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia.

Authors:  Emika Toyomitsu; Makoto Tsuda; Tomohiro Yamashita; Hidetoshi Tozaki-Saitoh; Yoshitaka Tanaka; Kazuhide Inoue
Journal:  Purinergic Signal       Date:  2012-01-06       Impact factor: 3.765

3.  Chronic inflammation and pain in a tumor necrosis factor receptor (TNFR) (p55/p75-/-) dual deficient murine model.

Authors:  Karin N Westlund; Liping Zhang; Fei Ma; Helieh S Oz
Journal:  Transl Res       Date:  2011-11-08       Impact factor: 7.012

4.  Association between IL-33 and other inflammatory factors in patients with rheumatoid arthritis and in fibroblast-like synoviocytes in vitro.

Authors:  Jing Wu; Qiang Li; Jiaxin Deng; Jin-Jun Zhao; Qing-Hong Yu
Journal:  Exp Ther Med       Date:  2020-12-18       Impact factor: 2.447

5.  Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes.

Authors:  K Varani; F Vincenzi; A Tosi; M Targa; F F Masieri; A Ongaro; M De Mattei; L Massari; P A Borea
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

6.  Joint tissues amplify inflammation and alter their invasive behavior via leukotriene B4 in experimental inflammatory arthritis.

Authors:  Mei Chen; Bing K Lam; Andrew D Luster; Simona Zarini; Robert C Murphy; Angela M Bair; Roy J Soberman; David M Lee
Journal:  J Immunol       Date:  2010-09-27       Impact factor: 5.422

7.  Interleukin-32gamma enhances the production of IL-6 and IL-8 in fibroblast-like synoviocytes via Erk1/2 activation.

Authors:  Yong-Gil Kim; Chang-Keun Lee; Soo-Hyun Kim; Woo-Shin Cho; Se Hwan Mun; Bin Yoo
Journal:  J Clin Immunol       Date:  2010-01-14       Impact factor: 8.317

Review 8.  Chemokines in joint disease: the key to inflammation?

Authors:  J J Haringman; J Ludikhuize; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

9.  Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies.

Authors:  T McNearney; B A Baethge; S Cao; R Alam; J R Lisse; K N Westlund
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

10.  Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis.

Authors:  J J Haringman; M C Kraan; T J M Smeets; K H Zwinderman; P P Tak
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.